Rey, D <br/><br/>
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  Feb 2009 
 - 380-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2091 
<br/><br/><label>Standard No.: </label>10.1093/jac/dkn471  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--administration & dosage<br/>Adult<br/>Amino Acid Substitution--genetics<br/>Anti-HIV Agents--administration & dosage<br/>CD4 Lymphocyte Count<br/>Drug Resistance, Viral<br/>Female<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Lamivudine--administration & dosage<br/>Male<br/>Middle Aged<br/>Mutation, Missense<br/>Nevirapine--administration & dosage<br/>Organophosphonates--administration & dosage<br/>Tenofovir<br/>Treatment Outcome<br/>Viral Load<br/>Viral Proteins--genetics